Showing 1 - 10 of 1,159
Persistent link: https://www.econbiz.de/10012879946
Persistent link: https://www.econbiz.de/10014427741
Persistent link: https://www.econbiz.de/10012016688
Persistent link: https://www.econbiz.de/10014293299
The amendments to the International Health Regulations (2005) (IHR) agreed upon in May 2024 are important for strengthening global health emergency preparedness and response. The negotiations resulted in the IHR amendment now recognizing the importance of equity, including equitable access to...
Persistent link: https://www.econbiz.de/10015051588
Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But...
Persistent link: https://www.econbiz.de/10014422476
Persistent link: https://www.econbiz.de/10001715274
Directing government subsidies to social services such as health care is expected to bring about positive external/social benefits and improve equity in access to health services. In general, government spending on health is envisioned to improve the well-being of beneficiaries and enhance their...
Persistent link: https://www.econbiz.de/10011421191
Cost-effectiveness analysis often plays an important role in prioritization among different types of public health expenditures. Cost-effectiveness is defined as the maximal health benefits for given expenditures on health care. With a private health sector as a supplement to the public sector,...
Persistent link: https://www.econbiz.de/10010284383
Persistent link: https://www.econbiz.de/10001509732